HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treating thyroid nodules by radiofrequency: is the delivered energy correlated with the volume reduction rate? A pilot study.

AbstractOBJECTIVE:
Radiofrequency ablation (RFA) was proven as effective in reducing thyroid nodules' volume. However, whether technical procedure aspects could influence the volume reduction rate (VRR) has not been clarified. This retrospective pilot study aimed to analyze the correlation of RFA power, duration, and energy with VRR.
METHODS:
During the period from June to December 2018 two primary-care centers treated benign thyroid nodules of adult outpatients according to the same RFA procedure. Technical parameters to be investigated were the following: median power (Pmedian), effective time of treatment (Teff), energy calculated as Pmedian × Teff (Ecalc), and energy delivered per mL as Kcal × 4184 × nodule's volume (Edel). Continuous variables were analyzed by the Mann-Whitney test. Data of 1-year posttreatment follow-up were collected on December 2019 and the correlation of the above parameters with VRR was analyzed by linear regression.
RESULTS:
Forty-one nodules were included and their 1-year VRR was 66.6%. RFA was performed with a Pmedian of 55 W, Teff 10.24 min, Ecalc 31,380 J, and Edel 1473 J/mL. Edel was significantly correlated with VRR (p = 0.014) while Pmedian, Teff, and Ecalc not. A strong correlation of Edel with VRR was found in nodules <10 mL (p = 0.001) while no significant correlation was observed in nodules >10 mL.
CONCLUSIONS:
This study showed that the energy delivered with RFA is the only technical parameter significantly correlated with the VRR of thyroid nodules.
AuthorsPierpaolo Trimboli, Maurilio Deandrea
JournalEndocrine (Endocrine) Vol. 69 Issue 3 Pg. 682-687 (09 2020) ISSN: 1559-0100 [Electronic] United States
PMID32319012 (Publication Type: Journal Article)
Topics
  • Adult
  • Humans
  • Pilot Projects
  • Radiofrequency Ablation
  • Retrospective Studies
  • Thyroid Nodule (surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: